Clinical Trials Logo

Clinical Trial Summary

The goal of this observational study is to learn about functional heterogeneity of immune cells before and after cardiopulmonary bypass (CPB) in children with congenital heart disease (CHD). The main question[s] it aims to answer are: - Does CPB cause immune paralysis after CHD surgery? - How does the functional heterogeneity of immune cells change before and after CPB in children undergoing CHD surgery? Participants will receive 3ml of peripheral blood before CPB, 2 hours after CPB, and 3 days after CPB, and the peripheral blood samples will be sequenced by single cell to explore the immune heterogeneity before and after CPB.


Clinical Trial Description

CPB-induced immune paralysis is the main cause of postoperative infection in CHD, which seriously affects the prognosis of children. The underlying mechanism of CPB-induced immune paralysis has not been fully determined. This study intends to use scRNA-seq to describe gene transcription profiles of immune cells in peripheral blood of children undergoing CHD surgery before and after CPB, and explore the differences within and between different immune cell populations including T cells and the changes of immune cells in different sequences. To fill the gap in the study of immune mechanism in CPB-induced immune paralysis microenvironment at single-cell resolution. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06214182
Study type Observational [Patient Registry]
Source The Children's Hospital of Zhejiang University School of Medicine
Contact
Status Enrolling by invitation
Phase
Start date January 1, 2024
Completion date December 31, 2024

See also
  Status Clinical Trial Phase
Completed NCT03684161 - Cardiopulmonary Function in Adults Born With a Ventricular Septal Defect
Completed NCT01120964 - Intravenous L-Citrulline to Treat Children Undergoing Heart Bypass Surgery : Revised Protocol Phase 1/Phase 2
Completed NCT02914652 - The Cardiopulmonary Effect of Inhaled Beta-2-agonists on Adult Patients Born With Ventricular Septum Defects. Phase 4
Recruiting NCT05939713 - Cera™ VSD Occluder Post Market Clinical Follow-up
Recruiting NCT05688670 - Regional Anesthesia Following Pediatric Cardiac Surgery Phase 4
Completed NCT02138435 - Longterm Outcome After Ventricular Septal Defect Closure N/A
Not yet recruiting NCT06298344 - The Role of Thiamine After Transcatheter Closure in Children With Left-to-Right Shunt Congenital Heart Disease Early Phase 1
Recruiting NCT05253209 - A Study Evaluating the Efficacy and Safety of IV L-Citrulline for the Prevention of Clinical Sequelae of Acute Lung Injury Induced by Cardiopulmonary Bypass in Pediatric Patients Undergoing Surgery for Congenital Heart Defects Phase 3
Completed NCT00556361 - Use of Ketamine Prior to Cardiopulmonary Bypass in Children Phase 2
Completed NCT05200910 - The Effect of Transcatheter VSD Closure on Children's Appetite, Hormones and Growth
Recruiting NCT03127748 - Cardiac Function After Transcatheter VSD Closure N/A
Active, not recruiting NCT04667455 - Improving Care for Children With Congenital Heart Disease. N/A
Completed NCT04417712 - Lifetech KONAR MFO Post-Market Clinical Follow-Up Study
Completed NCT01313832 - The Effect of Remote Ischemic Preconditioning on the Ischemic Reperfusion Injury in Infants With Ventricular Septal Defect and Pulmonary Hypertension N/A
Active, not recruiting NCT04017975 - Optical Tissue Identification for Myocardial Architecture Phase 2
Completed NCT01915277 - A Phase I Study of Dexmedetomidine Bolus and Infusion in Corrective Infant Cardiac Surgery: Safety and Pharmacokinetics Phase 1
Recruiting NCT03941691 - A Trial to Evaluate the Safety and Efficacy of a Fully Degradable Ventricular Septal Defect (VSD) Closure N/A
Completed NCT04859036 - The Effect of Transcatheter Ventricular Septal Defect Closure on Heart Rate Variability Parameters